Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rieckmann

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Neurovirology|April 5, 2005
Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesionsHervé Perron, Françoise Lazarini, Klemens Ruprecht, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering GroupPeter Rieckmann, Alexey Boyko, Diego Centonze, et al.
Journal of Autoimmunity|December 31, 2013
Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cellsWen-Yu Chuang, Philipp Ströbel, Anna-Lena Bohlender-Willke, et al.
Journal of Neurology|April 27, 2018
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational studyKonstantin Huhn, Antonios Bayas, Sebastian Doerck, et al.
Neurology and Therapy|February 15, 2020
Cladribine Tablets and Relapsing-Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to KnowMohamed AlJumah, Mona Marwan Alkhawajah, Shireen Qureshi, et al.
Advances in Therapy|September 6, 2019
Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS CareCelia Oreja-Guevara, Stanca Potra, Birgit Bauer, et al.
Heliyon|February 23, 2023
Expert opinion on the pharmacological management of multiple sclerosis in women of childbearing age in IraqHayder K Hassoun, Akram Almahdawi, Sarwer Jamal Al-Bajalan, et al.
Advances in Therapy|October 9, 2023
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis CareCelia Oreja-Guevara, Stanca Potra, Birgit Bauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2012
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndromeGiancarlo Comi, Vittorio Martinelli, Mariaemma Rodegher, et al.
Plos One|February 14, 2008
mtDNA nt13708A variant increases the risk of multiple sclerosisXinhua Yu, Dirk Koczan, Anna-Maija Sulonen, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Neurovirology|April 5, 2005
Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesionsHervé Perron, Françoise Lazarini, Klemens Ruprecht, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering GroupPeter Rieckmann, Alexey Boyko, Diego Centonze, et al.
Journal of Autoimmunity|December 31, 2013
Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cellsWen-Yu Chuang, Philipp Ströbel, Anna-Lena Bohlender-Willke, et al.
Journal of Neurology|April 27, 2018
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational studyKonstantin Huhn, Antonios Bayas, Sebastian Doerck, et al.
Neurology and Therapy|February 15, 2020
Cladribine Tablets and Relapsing-Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to KnowMohamed AlJumah, Mona Marwan Alkhawajah, Shireen Qureshi, et al.
Advances in Therapy|September 6, 2019
Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS CareCelia Oreja-Guevara, Stanca Potra, Birgit Bauer, et al.
Heliyon|February 23, 2023
Expert opinion on the pharmacological management of multiple sclerosis in women of childbearing age in IraqHayder K Hassoun, Akram Almahdawi, Sarwer Jamal Al-Bajalan, et al.
Advances in Therapy|October 9, 2023
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis CareCelia Oreja-Guevara, Stanca Potra, Birgit Bauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2012
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndromeGiancarlo Comi, Vittorio Martinelli, Mariaemma Rodegher, et al.
Plos One|February 14, 2008
mtDNA nt13708A variant increases the risk of multiple sclerosisXinhua Yu, Dirk Koczan, Anna-Maija Sulonen, et al.
Pageof 13